Related Experiment Videos

Distal splenorenal shunt (DSS) in children: analysis of the first 21 consecutive cases

Annals of Surgery
|April 1, 1982
PubMed

Insights

Distal splenorenal shunt (DSS) effectively treats esophageal hemorrhage in children. This surgical procedure demonstrates long-term shunt patency and cessation of bleeding, with no instances of hepatic encephalopathy in successful cases.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Vascular Surgery

Background:

  • Esophageal hemorrhage is a serious complication in children.
  • Distal splenorenal shunt (DSS) is a surgical option for managing such bleeding.
  • Evaluating the efficacy and safety of DSS in pediatric patients is crucial.

Purpose of the Study:

  • To assess the safety and effectiveness of distal splenorenal shunt (DSS) in treating esophageal hemorrhage in children.
  • To evaluate shunt patency and long-term outcomes following DSS surgery.
  • To investigate hemodynamic changes and collateralization patterns after DSS.

Main Methods:

  • Twenty-one pediatric patients (ages 4-12) underwent distal splenorenal shunt (DSS) for esophageal hemorrhage.
  • Patients were followed for 0.5 to 6 years post-operatively.
  • Late angiographic studies were performed to assess shunt function and portal vein flow.

Main Results:

  • Seventeen out of 21 patients achieved long-term shunt patency.
  • Esophageal variceal hemorrhage ceased in all 17 successful cases.
  • No cases of hepatic encephalopathy were observed in patients with successful shunts.

Conclusions:

  • Distal splenorenal shunt (DSS) is a safe and effective surgical treatment for pediatric esophageal bleeding.
  • The procedure demonstrates good long-term patency rates and prevents hepatic encephalopathy.
  • DSS facilitates forward portal vein flow and significant portosystemic collateralization.

Related Concept Videos